For launch of five generic injectable ANDAs in the US
Caplin Point Laboratories announced that its subsidiary, Caplin Steriles has entered into a private label distribution agreement with Xellia Pharmaceuticals for five generic injectable ANDAs in the US. The first product is expected to be launched shortly, while approvals for the remaining are expected in the next 12-18 months.Powered by Capital Market - Live News
(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)
First Published: Tue, July 07 2020. 10:35 IST
July 07, 2020 at 12:05PM
https://ift.tt/31RD4e0
Caplin Steriles enters into private label distribution agreement with Xellia Pharmaceuticals - Business Standard
https://ift.tt/3fbzbE8
Bagikan Berita Ini
0 Response to "Caplin Steriles enters into private label distribution agreement with Xellia Pharmaceuticals - Business Standard"
Post a Comment